Fda Nih 2024 D1s07 Q

The first of three Q&A discussion panels from the

This presentation provided an overview of CDRH's Medical Device Development Tools (MDDT) Program and explained what ...

This presentation explored medical device coverage initiatives and the role of the Payor Communication Task Force in connecting ...

The last of three Q&A discussion panels from the

This presentation discussed a rundown of the Do's and Don'ts from

This presentation explained the role and function of the Division of Industry and Consumer Education (DICE) within the

This presentation provided comprehensive guidance on CDER's nonclinical resources for approaching First-in-Human (FIH) ...

The second of three Q&A discussion panels from the

This presentation introduced CBER's Manufacturers Assistance and Technical Training Branch (MATTB) and explained their ...

The second of two Q&A discussion panels for day one of the Clinical Investigator Training Course. ***No Timestamps*** Panelists: ...

This presentation addressed the revision of ICH Q2(R1) through Q2(R2)/Q14 guidelines on analytical procedure validation and ...

This presentation provided registration and listing exemptions and explained the legal status conferred by registration and listing ...

This presentation highlighted key clinical regulatory issues encountered during early-phase development of cellular and gene ...

The Generic Drugs Forum's first of four Q&A discussion panels, bringing together the speakers from the first session of day one.

NIH

This presentation explored regulatory resources and avenues for obtaining early guidance from CBER's Office of Therapeutic ...

Air date: Wednesday, February 1, 2023, 12PM Description: The Introduction to the Principles and Practice of Clinical Research ...

NIH

Air date: Wednesday, February 1, 2023, 12PM Description: The Introduction to the Principles and Practice of Clinical Research ...

NIH